open access

Vol 23, No 3 (2018)
Original research articles
Published online: 2018-05-01
Submitted: 2017-05-31
Get Citation

11C-methionine positron emission tomography for target delineation o frecurrent glioblastoma in re-irradiation planning

Hidekazu Tanaka, Takahiro Yamaguchi, Kae Hachiya, Kazuhiro Miwa, Jun Shinoda, Masahide Hayashi, Shinichi Ogawa, Hironori Nishibori, Satoshi Goshima, Masayuki Matsuo
DOI: 10.1016/j.rpor.2018.04.003
·
Rep Pract Oncol Radiother 2018;23(3):215-219.

open access

Vol 23, No 3 (2018)
Original research articles
Published online: 2018-05-01
Submitted: 2017-05-31

Abstract

Aim

To define the optimal margin on MRI scans in the re-radiation planning of recurrent glioblastoma using methionine positron emission tomography (MET-PET).

Background

It would be very useful if the optimal margin on MRI to cover the uptake area on MET-PET is known.

Materials and Methods

CT, MRI, and MET-PET were performed separately over the course of 2 weeks. Among the MRI scans, we used the contrast-enhanced T1-weighted images (Gd-MRI) and T2-weighted images (T2-MRI). The Gd-MRI-based clinical target volume (CTV) (CTV-Gd) and the T2-MRI-based CTV (CTV-T2) were defined as the contrast-enhanced area on Gd-MRI and the high intensity area on T2-MRI, respectively. We defined CTV x mm (x[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]5, 10, 15, 20) as x mm outside the CTV. MET-PET-based CTV (CTV-MPET) was defined as the area of accumulation of MET-PET. We calculated the sensitivity and specificity of CTV-Gd and CTV-T2 following comparison with CTV-MPET, which served as the gold standard in this study.

Results

The sensitivity of CTV-T2 5[[ce:hsp sp="0.25"/]]mm (98%) was significantly higher than CTV-T2 (87%), and there was no significant difference in the sensitivity between CTV-T2 5[[ce:hsp sp="0.25"/]]mm and CTV T2 10, 15, or 20[[ce:hsp sp="0.25"/]]mm. The sensitivity of CTV-Gd 20[[ce:hsp sp="0.25"/]]mm (97%) was lower than that of CTV-T2 5[[ce:hsp sp="0.25"/]]mm (98%).

Conclusions

A margin of at least 5[[ce:hsp sp="0.25"/]]mm around the high intensity area on T2-MRI is necessary in the target volume delineation of recurrent glioblastoma for the coverage of MET-PET findings in re-radiation therapy planning.

Abstract

Aim

To define the optimal margin on MRI scans in the re-radiation planning of recurrent glioblastoma using methionine positron emission tomography (MET-PET).

Background

It would be very useful if the optimal margin on MRI to cover the uptake area on MET-PET is known.

Materials and Methods

CT, MRI, and MET-PET were performed separately over the course of 2 weeks. Among the MRI scans, we used the contrast-enhanced T1-weighted images (Gd-MRI) and T2-weighted images (T2-MRI). The Gd-MRI-based clinical target volume (CTV) (CTV-Gd) and the T2-MRI-based CTV (CTV-T2) were defined as the contrast-enhanced area on Gd-MRI and the high intensity area on T2-MRI, respectively. We defined CTV x mm (x[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]5, 10, 15, 20) as x mm outside the CTV. MET-PET-based CTV (CTV-MPET) was defined as the area of accumulation of MET-PET. We calculated the sensitivity and specificity of CTV-Gd and CTV-T2 following comparison with CTV-MPET, which served as the gold standard in this study.

Results

The sensitivity of CTV-T2 5[[ce:hsp sp="0.25"/]]mm (98%) was significantly higher than CTV-T2 (87%), and there was no significant difference in the sensitivity between CTV-T2 5[[ce:hsp sp="0.25"/]]mm and CTV T2 10, 15, or 20[[ce:hsp sp="0.25"/]]mm. The sensitivity of CTV-Gd 20[[ce:hsp sp="0.25"/]]mm (97%) was lower than that of CTV-T2 5[[ce:hsp sp="0.25"/]]mm (98%).

Conclusions

A margin of at least 5[[ce:hsp sp="0.25"/]]mm around the high intensity area on T2-MRI is necessary in the target volume delineation of recurrent glioblastoma for the coverage of MET-PET findings in re-radiation therapy planning.

Get Citation

Keywords

Glioblastoma; Radiation therapy; Magnetic resonance imaging; [[ce:sup loc=" pre" ]]11C methionine positron emission tomography

About this article
Title

11C-methionine positron emission tomography for target delineation o frecurrent glioblastoma in re-irradiation planning

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 23, No 3 (2018)

Pages

215-219

Published online

2018-05-01

DOI

10.1016/j.rpor.2018.04.003

Bibliographic record

Rep Pract Oncol Radiother 2018;23(3):215-219.

Keywords

Glioblastoma
Radiation therapy
Magnetic resonance imaging
[[ce:sup loc="pre"]]11C methionine positron emission tomography

Authors

Hidekazu Tanaka
Takahiro Yamaguchi
Kae Hachiya
Kazuhiro Miwa
Jun Shinoda
Masahide Hayashi
Shinichi Ogawa
Hironori Nishibori
Satoshi Goshima
Masayuki Matsuo

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl